Phase II Clinical Trial to Evaluate the Safety and Feasibility of Senolytic Therapy in Alzheimer's Disease. CTMS#: 21-0098
Lay Description
Category
- IRB Number
- 20210490HU
- NCT Number
- ct.gov registration not required
- Open to Enrollment
- Yes
Eligibility
- Eligible Ages
- Eligible Genders
- Accepts Healthy Volunteers
Inclusion Criteria
Exclusion Criteria
Study Design
Arm Groups
Study Contact
Valentina Garbarino
(615) 681-1268
garbarino@uthscsa.edu
Floyd Jones
+1 (210) 450-3158
jonesfa@uthscsa.edu
Floyd Jones
+1 (210) 450-3158
jonesfa@uthscsa.edu
Principal Investigator
Valentina Garbarino